DV Biomed Co., Ltd. (TPEX:6539)
Taiwan · Delayed Price · Currency is TWD 47.00
-3.90 (-7.66%)
Apr 20, 2026, 11:45 AM CST
DV Biomed Market Cap
DV Biomed has a market cap or net worth of 1.24 billion as of April 17, 2026. Its market cap has decreased by -5.27% in one year.
Market Cap
1.24B
Enterprise Value
957.10M
Revenue
794.18M
Ranking
n/a
PE Ratio
160.19
Stock Price
47.00
Market Cap Chart
Since October 15, 2015, DV Biomed's market cap has decreased from 5.01B to 1.24B, a decrease of -75.25%. That is a compound annual growth rate of -12.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.24B | -13.73% |
| Dec 31, 2025 | 1.44B | 11.93% |
| Dec 30, 2024 | 1.28B | -55.96% |
| Dec 29, 2023 | 2.91B | -11.33% |
| Dec 30, 2022 | 3.29B | -5.52% |
| Dec 30, 2021 | 3.48B | -17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TSH Biopharm Corporation | 1.95B |
| Tien Liang BioTech | 1.72B |
| GeneFerm Biotechnology | 1.64B |
| InnoPharmax | 1.57B |
| Winston Medical Supply | 1.26B |
| Excelsior Biopharma | 1.23B |
| Anxo Pharmaceutical | 1.17B |
| Prince Pharmaceutical | 1.12B |